Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”

Maria Adriana Cataldo; Nardi Tetaj; Nicola Petrosillo

doi:10.1016/j.jgar.2020.10.004

Perspective

Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”

CI 3.20

Oct 28, 2020

Published

Abstract

• COVID-19 patients have an exaggerated risk of acquiring BSI during ICU stay. • The incidence of ICU-acquired BSI in COVID-19 patients is higher than that reported in European ICUs in the pre-COVID-19 period. • The commonest aetiological agents of BSI were intestinal commensals. • A high rate of acquisition of VRE colonisation was observed.

Research Topics

Paper Details

Title: Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”
DOI: 10.1016/j.jgar.2020.10.004
Published: Oct 28, 2020
Journal
Volume: 23
Pages: 290–291